Literature DB >> 25581

Cyclophosphamide-induced remissions in advanced polyarteritis nodosa.

A S Fauci, J L Doppman, S M Wolff.   

Abstract

Two patients with far advanced polyarteritis nodosa involving multiple organ systems and with aneurysm formation demonstrable by celiac axis and renal arteriograms were treated with oral cyclophosphamide, 1 to 2 mg/kg/day, and alternate day prednisone therapy. Dramatic remissions of disease activity were achieved within weeks of initiation of therapy. Repeat angiograms obtained after one year revealed complete resolution of all aneurysms. Both patients are now receiving only cyclophosphamide and are maintained in complete remission 27 and 18 months after the start of therapy. Cyclophosphamide therapy can thus be highly effective even in far advanced polyarteritis nodosa.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25581     DOI: 10.1016/0002-9343(78)90533-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  Central nervous system polyarteritis nodosa.

Authors:  M R Rosenberg; M Parshley; S Gibson; R Wernick
Journal:  West J Med       Date:  1990-11

2.  Combined therapy with methotrexate and prednisone in polyarteritis nodosa.

Authors:  H Tannenbaum
Journal:  Can Med Assoc J       Date:  1980-11-08       Impact factor: 8.262

3.  Clinical features, treatment and outcome of polyarteritis nodosa.

Authors:  A Reeves; B Bresnihan
Journal:  Ir J Med Sci       Date:  1987-03       Impact factor: 1.568

Review 4.  Noninfectious immune-mediated uveitis and ocular inflammation.

Authors:  Jennifer Pan; Manuj Kapur; Rex McCallum
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 5.  Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart.

Authors:  Zhengping Huang; Tianwang Li; Peter A Nigrovic; Pui Y Lee
Journal:  Clin Immunol       Date:  2020-04-07       Impact factor: 3.969

Review 6.  Advances in therapy for ANCA-associated vasculitis.

Authors:  Duvuru Geetha; Philip Seo
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

7.  Course of cerebral lesions in a patient with periarteritis nodosa studied by magnetic resonance imaging.

Authors:  R Koppensteiner; W Base; H Bognar; A Kiss; M al Mubarak; D Tscholakoff
Journal:  Klin Wochenschr       Date:  1989-04-03

8.  Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis.

Authors:  C J Poulton; P H Nachman; Y Hu; J G McGregor; J C Jennette; R J Falk; S L Hogan
Journal:  Clin Exp Rheumatol       Date:  2013-01-23       Impact factor: 4.473

9.  Repressed ileal artery aneurysms in Churg-Strauss syndrome following combination treatment with glucocorticoid and cyclophosphamide.

Authors:  Akira Yamasaki; Katsuyuki Tomita; Yoshihiro Fujii; Yasuyuki Hasegawa; Masanari Watanabe; Hiroyuki Sano; Ryota Okazaki; Yasufumi Ouchi; Seiichi Nakamura; Eiji Shimizu
Journal:  Rheumatol Int       Date:  2008-08-08       Impact factor: 2.631

Review 10.  Systemic treatment of vitreous inflammation.

Authors:  John B Christoforidis; Susie Chang; Angela Jiang; Jillian Wang; Colleen M Cebulla
Journal:  Mediators Inflamm       Date:  2012-09-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.